New study aims to predict clot risk in PCOS patients

NCT ID NCT07571096

Recruiting now Knowledge-focused Sponsor: Guangdong Women and Children Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study is creating a risk assessment system to predict blood clotting abnormalities in women with polycystic ovary syndrome (PCOS). Researchers will analyze hormone, metabolic, and genetic factors in 100 participants aged 14 to 45. The goal is to help doctors personalize care and prevent complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a risk assessment tool to help doctors identify which women with PCOS are at higher risk for blood clotting problems, enabling earlier and more personalized care.
What could go wrong: This is an early observational study with only 100 participants, so the findings may not apply to all women with PCOS. The model needs further validation before it can be used in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME (PCOS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome thrombophilia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POLYCYSTIC OVARY SYNDROME (PCOS) THROMBOPHILIA

Contacts and locations

Locations

Guangdong Women and Children Hospital
RECRUITING

Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.